Of America Corp /De/ Bank Acquires 477 Shares of HCA Healthcare, Inc. (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCA) major shareholder Of America Corp /De/ Bank purchased 477 shares of the company’s stock in a transaction that occurred on Friday, January 13th. The stock was acquired at an average cost of $23.29 per share, for a total transaction of $11,109.33. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

HCA Healthcare Trading Down 0.0 %

NYSE:HCA opened at $342.25 on Friday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a market cap of $84.26 billion, a P/E ratio of 15.58, a P/E/G ratio of 1.10 and a beta of 1.68. The stock’s fifty day moving average price is $324.53 and its two-hundred day moving average price is $341.25.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the business earned $5.90 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.84%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is currently 13.11%.

Wall Street Analyst Weigh In

A number of research firms recently commented on HCA. Royal Bank of Canada lowered their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. Truist Financial reduced their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Bank of America cut their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. Finally, KeyCorp lowered their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $385.67.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of HCA. Larson Financial Group LLC grew its position in HCA Healthcare by 201.3% in the third quarter. Larson Financial Group LLC now owns 672 shares of the company’s stock worth $273,000 after acquiring an additional 449 shares in the last quarter. Independent Advisor Alliance lifted its position in HCA Healthcare by 20.5% in the 3rd quarter. Independent Advisor Alliance now owns 1,142 shares of the company’s stock worth $464,000 after buying an additional 194 shares during the last quarter. Private Trust Co. NA boosted its position in HCA Healthcare by 16.4% during the third quarter. Private Trust Co. NA now owns 1,137 shares of the company’s stock valued at $462,000 after buying an additional 160 shares during the period. D.A. Davidson & CO. lifted its stake in shares of HCA Healthcare by 61.3% in the 3rd quarter. D.A. Davidson & CO. now owns 4,042 shares of the company’s stock valued at $1,643,000 after acquiring an additional 1,536 shares during the last quarter. Finally, Avestar Capital LLC grew its holdings in shares of HCA Healthcare by 8.6% in the third quarter. Avestar Capital LLC now owns 901 shares of the company’s stock worth $366,000 after purchasing an additional 71 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.